Bull
$17.72
Scenario price
$10.240
+0.183 (+1.79%)At close
Bain Capital Specialty Finance, Inc. is an externally managed specialty finance company focused on lending to middle market companies. The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and, to a lesser extent, corporate bonds. Its primary focus is capitalizing on opportunities within Bain Capital Credit's Senior Direct Lending Strategy, which seeks to provide risk-adjusted returns and current income to investors by investing primarily in middle-market direct lending opportunities across North America, Europe and Australia and also in other geographic markets. It may also invest in mezzanine debt and other junior securities, including common and preferred equity and in secondary purchases of assets or portfolios. It is managed by BCSF Advisors, LP.
Bain Capital Specialty Finance Inc (BCSF) is not a strong buy at the moment due to its current price of $10.26, which is significantly below the analyst price target of $12.50 from Lucid Capital. Additionally, the RSI is at a low 24.972, indicating that the stock is oversold, but this could also suggest ongoing weakness. The forward P/E ratio of 10.11 shows attractive valuation, yet the stock has a concerning year-to-date change of -26.50%, indicating persistent downward pressure. The main risk is the hedge fund selling, which has increased by 136.38% over the last quarter, suggesting a lack of confidence among institutional investors.
Lucid Capital
$12.50
2026-09-18
Lucid Capital
2026-09-18
Price Target
$12.50
Wells Fargo
$12
2026-08-12
Wells Fargo
2026-08-12
Price Target
$12
BofA
$13
2026-03-09
BofA
2026-03-09
Price Target
$13
Keefe Bruyette
$15
2026-03-03
Keefe Bruyette
2026-03-03
Price Target
$15
Wells Fargo
$13
2026-03-03
Wells Fargo
2026-03-03
Price Target
$13
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bain Capital Reports Q2 2026 Financial Results

Bain Capital Specialty Finance Q2 Earnings Report Schedule

Bain Capital Specialty Finance Shares Oversold

Attractive Valuations in U.S. Mid-Cap Financial Stocks

Analysis of Special Dividend Investment Opportunities
Bain Capital Specialty Finance, Inc. is an externally managed specialty finance company focused on lending to middle market companies. The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and, to a lesser extent, corporate bonds. Its primary focus is capitalizing on opportunities within Bain Capital Credit's Senior Direct Lending Strategy, which seeks to provide risk-adjusted returns and current income to investors by investing primarily in middle-market direct lending opportunities across North America, Europe and Australia and also in other geographic markets. It may also invest in mezzanine debt and other junior securities, including common and preferred equity and in secondary purchases of assets or portfolios. It is managed by BCSF Advisors, LP. It operates in the Financials sector.
Bain Capital Specialty Finance Inc (BCSF) is not a strong buy at the moment due to its current price of $10.26, which is significantly below the analyst price target of $12.50 from Lucid Capital. Additionally, the RSI is at a low 24.972, indicating that the stock is oversold, but this could also suggest ongoing weakness. The forward P/E ratio of 10.11 shows attractive valuation, yet the stock has a concerning year-to-date change of -26.50%, indicating persistent downward pressure. The main risk is the hedge fund selling, which has increased by 136.38% over the last quarter, suggesting a lack of confidence among institutional investors.
6 analysts cover BCSF: 4 rate it Buy, 2 Hold and 0 Sell. The average price target is 14.83.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.